Hobday TJ - Search Results

1

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights.

Starr JS, Sonbol MB, Hobday TJ, Sharma A, Kendi AT, Halfdanarson TR. Starr JS, et al. Among authors: hobday tj. Onco Targets Ther. 2020 Apr 28;13:3545-3555. doi: 10.2147/OTT.S202867. eCollection 2020. Onco Targets Ther. 2020. PMID: 32431509 Free PMC article. Review.

2

Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.

Halfdanarson TR, Bamlet WR, McWilliams RR, Hobday TJ, Burch PA, Rabe KG, Petersen GM. Halfdanarson TR, et al. Among authors: hobday tj. Pancreas. 2014 Nov;43(8):1219-22. doi: 10.1097/MPA.0000000000000234. Pancreas. 2014. PMID: 25291526 Free PMC article.

3

The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms.

Xie H, Liu J, Yadav S, Keutgen XM, Hobday TJ, Strosberg JR, Halfdanarson TR. Xie H, et al. Among authors: hobday tj. Neuroendocrinology. 2020;110(3-4):234-245. doi: 10.1159/000501126. Epub 2019 May 24. Neuroendocrinology. 2020. PMID: 31121586

4

Renal Neuroendocrine Neoplasms: A Single-center Experience.

McGarrah PW, Westin GFM, Hobday TJ, Scales JA, Ingimarsson JP, Leibovich BC, Halfdanarson TR. McGarrah PW, et al. Among authors: hobday tj. Clin Genitourin Cancer. 2020 Aug;18(4):e343-e349. doi: 10.1016/j.clgc.2019.11.003. Epub 2019 Dec 5. Clin Genitourin Cancer. 2020. PMID: 31911122 Clinical Trial.

5

Efficacy of Second-Line Chemotherapy in Extrapulmonary Neuroendocrine Carcinoma.

McGarrah PW, Leventakos K, Hobday TJ, Molina JR, Finnes HD, Westin GF, Halfdanarson TR. McGarrah PW, et al. Among authors: hobday tj. Pancreas. 2020 Apr;49(4):529-533. doi: 10.1097/MPA.0000000000001529. Pancreas. 2020. PMID: 32282766 Free PMC article.

6

Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors.

Zhu M, Bassam Sonbol M, Halfdanarson T, Hobday T, Ahn D, Ma WW, Bekaii-Saab T. Zhu M, et al. Oncologist. 2020 Aug;25(8):e1246-e1248. doi: 10.1634/theoncologist.2020-0029. Epub 2020 Jul 1. Oncologist. 2020. PMID: 32510802 Free PMC article.

7

Holistic review for hematology-oncology fellowship applicants: A new paradigm?

Marshall AL, Halfdanarson TR, Nowakowski GS, Lacy MQ, Thompson CA, Hobday T. Marshall AL, et al. Am J Hematol. 2020 Oct;95(10):1124-1126. doi: 10.1002/ajh.25930. Epub 2020 Jul 29. Am J Hematol. 2020. PMID: 32628292 Free article. No abstract available.

8

Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors.

Liu AJ, Ueberroth BE, McGarrah PW, Buckner Petty SA, Kendi AT, Starr J, Hobday TJ, Halfdanarson TR, Sonbol MB. Liu AJ, et al. Among authors: hobday tj. Oncologist. 2021 May;26(5):383-388. doi: 10.1002/onco.13686. Epub 2021 Feb 8. Oncologist. 2021. PMID: 33496040 Free PMC article.

9

Pilot Study Characterizing the Hematology-Oncology Fellow Job Search Process: Tools Used and Identification of Potential New Resources.

Marshall AL, Halfdanarson TR, Alkhateeb H, Hobday T. Marshall AL, et al. J Cancer Educ. 2022 Oct;37(5):1385-1388. doi: 10.1007/s13187-021-01967-7. Epub 2021 Jan 30. J Cancer Educ. 2022. PMID: 33517561 Free PMC article.

10

Neuroendocrine Carcinoma of the Anus and Rectum: Patient Characteristics and Treatment Options.

Ueberroth BE, Liu AJ, Starr JS, Hobday TJ, Ashman JB, Mishra N, Bekaii-Saab TS, Halfdanarson TR, Sonbol MB. Ueberroth BE, et al. Among authors: hobday tj. Clin Colorectal Cancer. 2021 Jun;20(2):e139-e149. doi: 10.1016/j.clcc.2020.12.001. Epub 2020 Dec 17. Clin Colorectal Cancer. 2021. PMID: 33551318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters